Drawing for YOSITAN

USPTO serial 79064735

YOSITAN

Reviewed by CopyMark Law Group

Reg. 3752445Status 404
Filing date
Status date
Registration date
Feb 23, 2010
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with YOSITAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adrienne L. White

Adrienne L. White WRB-IP LLPPO BOX 476Wadsworth, OH 44282UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neuronal tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and multiple sclerosis, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematosus, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 26, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 26, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 24, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 16, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 16, 2017INPCINVALIDATION PROCESSED—
May 30, 2017INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 30, 2016C71TCANCELLED SECTION 71—
Feb 23, 2015REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 6, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 14, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 14, 2010FIMPFINAL DISPOSITION PROCESSED—
May 23, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 26, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 8, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 8, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 5, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 1, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 30, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2009CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 29, 2009ALIEASSIGNED TO LIE—
Sep 25, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 17, 2009RFNTREFUSAL PROCESSED BY IB—
Mar 25, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 25, 2009RFRRREFUSAL PROCESSED BY MPU—
Mar 25, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 24, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2009DOCKASSIGNED TO EXAMINER—
Feb 24, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 20, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance